Your SlideShare is downloading. ×
The Diabetes Market Outlook to 2016Published:May 2011No.Of Pages:132Price:US $ 3835IntroductionThis report provides compre...
withdrawal and has also delayed the launch of several late stage developmentproducts.Browse All Pharmaceuticals Market Res...
Bydureon approved in the EUEli Lilly and Boehringer Ingelheim’s collaborates over diabetes drugNovo Nordisk receives subpo...
Follow us on Twitter: http://twitter.com/marketsreportsOur Facebook Page:http://www.facebook.com/pages/ReportsnReports/191...
Upcoming SlideShare
Loading in...5
×

The diabetes market outlook to 2016

683

Published on

This report provides comprehensive coverage of the diabetes market, incorporating a disease overview and detailed epidemiological analyses of the therapy area. It makes a wide-ranging assessment of the marketed product portfolio, R&D pipeline, market-share data, sales forecasts and competitive landscape of the major players.

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
683
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
4
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Transcript of "The diabetes market outlook to 2016"

  1. 1. The Diabetes Market Outlook to 2016Published:May 2011No.Of Pages:132Price:US $ 3835IntroductionThis report provides comprehensive coverage of the diabetes market, incorporatinga disease overview and detailed epidemiological analyses of the therapy area. Itmakes a wide-ranging assessment of the marketed product portfolio, R&D pipeline,market-share data, sales forecasts and competitive landscape of the major players.The market size is forecast to 2016.Features and benefits* Quantify and assess the patient potential and treatment trends of diabetesglobally.* Understand how recent events are affecting the performance of major products,and how their marketers are confronting competitive challenges.* Benchmark the leading anti-diabetic pipeline products under development andevaluate the evolution of the market in the forecast period.* Identify the leading players in the diabetes market and analyze their marketedportfolios, R&D pipelines and market strategies.* Evaluate the key market trends and growth strategies that holds potential forshaping the future diabetes market.HighlightsDiabetes is the fifth leading cause of death in the developed countries. Diabetesprevalence is increasing at a fast pace in the developing countries due to lifestylechanges and a lack of awareness of its causes. This presents a huge opportunity tothe marketers of diabetes products.The diabetes landscape is dynamic, with active R&D leading to the development ofnewer drug classes such as incretin mimetics, and regulatory agencies such as theFDA having increased the regulatory surveillance over diabetes drugs to avoid any“unacceptable” cardiovascular risk.Stringent regulatory screening in the light of increasing reports of serious adverseevents of cardiovascular risk factors has had repercussions in terms of product
  2. 2. withdrawal and has also delayed the launch of several late stage developmentproducts.Browse All Pharmaceuticals Market Research ReportsYour key questions answered* What are the new therapy approaches in anti-diabetes market and which of theseoffer significant potential in the future?* What is the forecast commercial potential of the most promising compounds inclinical development?* Which products have been the major revenue generators in the market and whatother categories are forecast to have commercial potential through 2016?* What are the current growth drivers in the global diabetes market shaping thefuture?* How will the patient population of diabetes sufferers change between 2010 and2016?Table Of ContentsExecutive SummaryOverview and patient potential of diabetesGlobal market analysisPipeline analysisCompetitive landscapeAbout the authorDisclaimerOverview and patient potential of diabetesSummaryIntroductionWhat is diabetes?Types of diabetesType 2 diabetesGestational diabetes mellitusImpaired glucose toleranceDiabetic complicationsEpidemiologyDiagnosisHow is diabetes measured?Treatment algorithmGlobal market analysisSummaryIntroductionMarket analysis by countryIndiaChinaKey events/trends in the diabetes market
  3. 3. Bydureon approved in the EUEli Lilly and Boehringer Ingelheim’s collaborates over diabetes drugNovo Nordisk receives subpoena for three marketed productsNewer agents recommended by NICE for diabetes treatmentAmylin sues LillyMarket analysis by drug classDiabetes drug classesThe insulin landscapeDrugs targeting underlying causes of diabetesDPP-IV and GLP-1 differencesTherapy area sales forecastLeading brands of the diabetes marketLeading brands sales forecastPipeline analysisSummaryIntroductionEmerging trends/key events in diabetes R&DUnmet needInhaled insulin still a distant realityNew approaches in diabetes R&D: magnesium, chromium, and vanadiumRegulatory changes in the light of increasing cardiovascular adverse effectsProfiles of key pipeline productsProfiles of key moleculesPipeline sales forecastCompetitive LandscapeSummaryIntroductionDetailed analysis of the diabetes market playersNovo NordiskSanofiTakedaEli LillyMerck & Co.AppendixScopeMarket forecastEpidemiology forecastGlossary/AbbreviationsBibliography/ReferencesAbout Us:ReportsnReports is an online library of over 100,000+ market research reports andin-depth market research studies & analysis of over 5000 micro markets. Weprovide 24/7 online and offline support to our customers. Get in touch with us foryour needs of market research reports.
  4. 4. Follow us on Twitter: http://twitter.com/marketsreportsOur Facebook Page:http://www.facebook.com/pages/ReportsnReports/191441427571689Contact:Mr.Priyank7557 Rambler road,Suite727,Dallas,TX75231Tel: + 1 888 391 5441E-mail: sales@reportsandreports.comhttp://www.reportsnreports.comVisit our Market Research Blog

×